GL1X · GenesisL1 explorer

MolNFT v1 · #102691 · protein

Crystal structure of a putative lipoprotein (CD630_1653) from clostridium difficile 630 at 2.20 a resolution

4OTE: “Crystal structure of a putative lipoprotein (CD630_1653) from clostridium difficile 630 at 2.20 a resolution”. X-ray diffraction, 3 ligands (MSE, ZN, CL), 4 pockets (best druggability 0.72). MolNFT v1 #102691 on GenesisL1: 3D…

PDB
4OTE
Type
protein
Length
478 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lipoprotein
UniProt
Q186K7
Ligands
MSE, ZN, CL
Pockets
4 · best druggability 0.72

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALipoproteinprotein23841% helix, 24% strandQ186K7
BLipoproteinprotein24041% helix, 23% strandQ186K7

Ligands and binding sites

  • MSE · Selenomethionine · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 15 copies · chains A, B
  • CL · Chloride ion · ion · 6 copies · chains A, B
  • ACT · Acetate ion · additive · 6 copies · chains A, B
  • GOL · Glycerol · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14970.720.8158MSE, ACT
24670.720.8163MSE, ACT
3670.370.7814ACT
4550.270.7312empty

Interfaces

1 interface between chains.

  • A–B · 430 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (engineered).

Compared structures

  • 4OTE · Crystal structure of a putative lipoprotein (CD630_1653) from Clostridium difficile 630… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.